DEANNA MARTIN: Open Payments
NPI 1790193423 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 59 payments from 15 companies in 2025. Trend: 2023 $453 · 2024 $1,622 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $222 |
| UCB, Inc. | 11 | $184 |
| AstraZeneca Pharmaceuticals LP | 4 | $115 |
| Janssen Biotech, Inc. | 5 | $100 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Radius Health, Inc. | 3 | $80 |
| ABBVIE INC. | 3 | $67 |
| Invivyd Inc | 3 | $63 |
| Aurinia Pharma U.S., Inc. | 2 | $50 |
Products named: Bimzelx, SAPHNELO, KRYSTEXXA, TREMFYA, BENLYSTA, Tymlos, PEMGARDA, ENBREL.
Industry payments across IL — which companies pay providers there.
